David M. Goldenberg, Sc.D., M.D., spent 60 years conducting cancer research and was a medical school professor who founded two cancer centers as well as Immunomedics, Inc. He directed the development of Trodelvy(R), an antibody-drug combination approved by the U.S. FDA and several foreign health authorities for the treatment of certain advanced cancers. The sense of smell, the focus on this novel, stems from his studies at the Universities of Erlangen and Heidelberg in Germany, after graduating with an S.B. from the University of Chicago.
